Autoantibodies in Systemic Autoimmune Disorders
1INOVA Diagnostics, San Diego, CA, USA
2Division of Rheumatology, Department of Internal Medicine, University of Texas, Medical Branch, Galveston ,TX, USA
3Department of Rheumatology, University of Milan, Milan, Italy
4Faculty of Medicine, University of Calgary, Calgary, AB, Canada
Autoantibodies in Systemic Autoimmune Disorders
Description
We invite authors to submit original research and review articles that seek to provide novel insights in the B-cell immune response of systemic autoimmune diseases. We are interested in articles that explore novel aspects of autoantibody detection as an aid in the diagnosis of systemic autoimmunity and also in in vivo aspects of autoantibodies. Potential topics include, but are not limited to:
- Novel, cutting-edge technologies for the identification of autoantigens
- Novel biomarkers in autoimmunity
- Diagnostic, clinical, and prognostic significance of autoantibodies
- Performance and analytical characteristics of novel immunoassays for autoantibody testing
- Engineered designer autoantigens: peptides and recombinant antigens
Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/jir/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/jir/asads/ according to the following timetable: